Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-026470

Acting Chief Business Officer sold 20,000 shares at an average $15.18 ($303,593)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Savill Corrine Acting Chief Business Officer 2022-07-18 Sale −5,042 $15.06 $75,933 164,573 D: show line 1 in the form
Savill Corrine Acting Chief Business Officer 2022-07-19 Sale −14,958 $15.22 $227,661 149,615 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $15.18 · $303,593
Loading xslF345X03/doc4.xml…